BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35818021)

  • 1. Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample.
    Brattmyr M; Lindberg MS; Solem S; Hjemdal O; Havnen A
    BMC Psychiatry; 2022 Jul; 22(1):461. PubMed ID: 35818021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties and measurement invariance of the 7-item General Anxiety Disorder scale (GAD-7) in an Italian coronary heart disease population.
    Bolgeo T; Di Matteo R; Simonelli N; Dal Molin A; Lusignani M; Bassola B; Vellone E; Maconi A; Iovino P
    J Affect Disord; 2023 Aug; 334():213-219. PubMed ID: 37149049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the Patient Health Questionnaire-4 scale and its subscales of depression and anxiety among US adults based on nativity.
    Adzrago D; Walker TJ; Williams F
    BMC Psychiatry; 2024 Mar; 24(1):213. PubMed ID: 38500115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain Injury.
    Teymoori A; Real R; Gorbunova A; Haghish EF; Andelic N; Wilson L; Asendorf T; Menon D; von Steinbüchel N
    J Affect Disord; 2020 Feb; 262():278-285. PubMed ID: 31732280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are comparisons of mental disorders between Chinese and German students possible? An examination of measurement invariance for the PHQ-15, PHQ-9 and GAD-7.
    Zhou Y; Xu J; Rief W
    BMC Psychiatry; 2020 Oct; 20(1):480. PubMed ID: 33004042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of the Patient Health Questionnaire scale (PHQ-9) among university students of Bangladesh.
    Rahman MA; Dhira TA; Sarker AR; Mehareen J
    PLoS One; 2022; 17(6):e0269634. PubMed ID: 35675375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement invariance of the PHQ-9 and GAD-7 across males and females seeking treatment for common mental health disorders.
    Saunders R; Moinian D; Stott J; Delamain H; Naqvi SA; Singh S; Wheatley J; Pilling S; Buckman JEJ
    BMC Psychiatry; 2023 Apr; 23(1):298. PubMed ID: 37118684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexuality and gender invariance of the PHQ-9 and GAD-7: Implications for 16 identity groups.
    Borgogna NC; Brenner RE; McDermott RC
    J Affect Disord; 2021 Jan; 278():122-130. PubMed ID: 32956961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care.
    Cano-Vindel A; Muñoz-Navarro R; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Gómez-Castillo MD; Capafons A; Chacón F; Santolaya F;
    J Affect Disord; 2018 Jul; 234():247-255. PubMed ID: 29549826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder.
    Huang XJ; Ma HY; Wang XM; Zhong J; Sheng DF; Xu MZ
    J Affect Disord; 2022 Aug; 311():327-335. PubMed ID: 35598748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic.
    Shevlin M; Butter S; McBride O; Murphy J; Gibson-Miller J; Hartman TK; Levita L; Mason L; Martinez AP; McKay R; Stocks TV; Bennett KM; Hyland P; Vallieres F; Valiente C; Vazquez C; Contreras A; Peinado V; Trucharte A; Bertamini M; Panzeri A; Bruno G; Granziol U; Mignemi G; Spoto A; Vidotto G; Bentall RP
    BMC Psychiatry; 2022 Mar; 22(1):154. PubMed ID: 35232409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement invariance and differential item functioning of the PHQ-9 and GAD-7 between working age and older adults seeking treatment for common mental disorders.
    Delamain H; Buckman JEJ; Stott J; John A; Singh S; Pilling S; Saunders R
    J Affect Disord; 2024 Feb; 347():15-22. PubMed ID: 37989437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the Polish version of the
    Basińska BA; Kwissa-Gajewska Z
    Int J Occup Med Environ Health; 2023 Nov; 36(4):493-504. PubMed ID: 37737500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of the Generalized Anxiety Disorder-7 (GAD-7) among university students of Bangladesh.
    Dhira TA; Rahman MA; Sarker AR; Mehareen J
    PLoS One; 2021; 16(12):e0261590. PubMed ID: 34914811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): Initial validation of structural validity in dialysis patients.
    Chilcot J; Hudson JL; Moss-Morris R; Carroll A; Game D; Simpson A; Hotopf M
    Gen Hosp Psychiatry; 2018; 50():15-19. PubMed ID: 28985589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the GAD-7 (General Anxiety Disorder-7): a cross-sectional study of the Peruvian general population.
    Villarreal-Zegarra D; Paredes-Angeles R; Mayo-Puchoc N; Arenas-Minaya E; Huarcaya-Victoria J; Copez-Lonzoy A
    BMC Psychol; 2024 Apr; 12(1):183. PubMed ID: 38566138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample.
    Sawaya H; Atoui M; Hamadeh A; Zeinoun P; Nahas Z
    Psychiatry Res; 2016 May; 239():245-52. PubMed ID: 27031595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.
    Löwe B; Wahl I; Rose M; Spitzer C; Glaesmer H; Wingenfeld K; Schneider A; Brähler E
    J Affect Disord; 2010 Apr; 122(1-2):86-95. PubMed ID: 19616305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent structure and factor invariance of somatic symptoms in the patient health questionnaire (PHQ-15).
    Cano-García FJ; Muñoz-Navarro R; Sesé Abad A; Moretti LS; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Moriana JA; Cano-Vindel A
    J Affect Disord; 2020 Jan; 261():21-29. PubMed ID: 31600584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7.
    Stochl J; Fried EI; Fritz J; Croudace TJ; Russo DA; Knight C; Jones PB; Perez J
    Assessment; 2022 Apr; 29(3):355-366. PubMed ID: 33269612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.